Humans1,112 patients21 monthsCohort study

Lipoprotein(a) reduction with PCSK9-targeting pharmacotherapy: A prospective real-world registry study

Graphical abstract from Atherosclerosis
Open the figure at full size
Graphical abstractKafol et al.

Atherosclerosis

The paper

Ljubljana University Medical Centre

Atherosclerosis · 23 Sep 2026

doi.org/10.1016/j.atherosclerosis.2026.121912PubMed 42809906

More on Lipid and ceramide metabolism